Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

Author： Gökmen-Polar Yesim   Toroni Rachel   Hocevar Barbara   Badve Sunil   Zhao Qianqian   Shen Changyu   Bruckheimer Elizabeth   Kinch Michael   Miller Kathy  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.127, Iss.2, 2011-06, pp. : 375-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer

By Kenny F.S.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

By Kinch Michael   Carles-Kinch Kelly  

Clinical and Experimental Metastasis, Vol. 20, Iss. 1, 2003-02 ,pp. : 59-68

Springer Publishing Company

Access to resources Recommend Favorite

Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer

By Buzdar A.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 161-175

Springer Publishing Company

Access to resources Recommend Favorite

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

By Reijm E.  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite

EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells

By          

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 41-46

Spandidos Publications

Access to resources Recommend Favorite